Drug Report History #241852

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language (Changed) Updated to: English Was: French
Date Updated (Changed) Updated to: 2025-10-08 Was: 2024-11-01
Drug Identification Number 02489635 02489635
Brand name DORZOLAMIDE AND TIMOLOL EYE DROPS BP DORZOLAMIDE AND TIMOLOL EYE DROPS BP
Common or Proper name DORZOLAMIDE AND TIMOLOL EYE DROPS BP DORZOLAMIDE AND TIMOLOL EYE DROPS BP
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients TIMOLOL DORZOLAMIDE TIMOLOL DORZOLAMIDE
Strength(s) 5MG 20MG 5MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size (Changed) Updated to: 100ml Was: 10mL
Additional packaging sizes
ATC code S01ED S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2024-10-31 2024-10-31
Remaining supply date 2024-10-31 2024-10-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments (Changed) Updated to: testing information on company comments Was:
Health Canada comments